TEVA 3145 (Cephalexin monohydrate 250 mg)

Pill imprint TEVA 3145 has been identified as Cephalexin monohydrate 250 mg.

Cephalexin is used in the treatment of bacterial infection; skin infection; bladder infection; upper respiratory tract infection; acne (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for TEVA 3145

Cephalexin monohydrate 250 mg TEVA 3145
Cephalexin monohydrate 250 mg TEVA 3145
Cephalexin monohydrate
Imprint:
TEVA
3145
Strength:
250 mg
Color:
Gray / Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
First generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-3145

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)